Fluticasone Propionate Orally Disintegrating Tablet (APT-1011) for Eosinophilic Esophagitis: Randomized Controlled Trial
Evan S. Dellon, Alfredo J. Lucendo, Christoph Schlag, Alain Schoepfer, Gary W. Falk, Gina Eagle, James Nezamis, Gail M. Comer, Karol Knoop, Ikuo Hirano
Topics & Concepts
MedicineEosinophilic esophagitisPlaceboGastroenterologyDysphagiaFluticasone propionateInternal medicineAdverse effectFluticasoneRandomized controlled trialSurgeryCorticosteroidAlternative medicineDiseasePathologyEosinophilic EsophagitisFood Allergy and Anaphylaxis ResearchEosinophilic Disorders and Syndromes